Join the $1K to $100K Trading Challenge! - https://bit.ly/1kto100ktradingchallenge
3 extracted signals · 1 resolved · 2 still active
Altcoin Doctor09 Sept 2025, 19:38 UTC
AI-generated source summary
The video provides a technical analysis of the cryptocurrency market, focusing on altcoins and Bitcoin dominance. It suggests a possible 600% increase for GALA, estimating a target price of $0.11294 using Fibonacci retracement on the weekly timeframe, with a failure bound of $0.01. The analysis highlights a decreasing USDT dominance, anticipating a potential drop to 2.00, a bullish indicator for the crypto market, invalidation occurs at 5.0. Bitcoin dominance is predicted to fall to 40.00, which has already begun, indicating an altcoin season and to continue. The total crypto market cap is projected to reach 5.62T, initial pull back around 3.5T with all-time highs at 1.66T. This all points to a massive altcoin season
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
2 signals remain active.
Signals in this source
More Prediction Case Files from Altcoin Doctor
SUI - THE EXPONENTIAL BLOCK - SUI Price Prediction
SOLANA - THE EXPONENTIAL BLOCK - SOLANA Price Prediction
RENDER - THE EXPONENTIAL BLOCK - RENDER Price Prediction
NEAR - THE EXPONENTIAL BLOCK - NEAR Price Prediction
AAVE - THE EXPONENTIAL BLOCK - AAVE Price Prediction
VECHAIN - THE EXPONENTIAL BLOCK - VET Price Prediction
Altcoin Doctor
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.


